March 20, 2018 / 11:32 AM / 4 months ago

BRIEF-Cotinga Pharmaceuticals Provides Update On COTI-2 Clinical Programs

March 20 (Reuters) - Cotinga Pharmaceuticals Inc:

* COTINGA PHARMACEUTICALS PROVIDES UPDATE ON COTI-2 CLINICAL PROGRAMS

* COTINGA PHARMACEUTICALS - SUBMITTED AN UPDATED CLINICAL PACKAGE TO REGULATORY AUTHORITIES TO EXPAND ITS ONGOING PHASE 1 TRIAL OF COTI-2

* COTINGA PHARMACEUTICALS - PROTOCOL AMENDMENT WILL EXPAND CLINICAL TRIAL TO EVALUATE COTI-2 AS COMBINATION THERAPY IN WIDE SPECTRUM OF CANCERS

* COTINGA - PENDING REGULATORY APPROVAL & SUFFICIENT FINANCING, EXPECTS TO IMPLEMENT PROTOCOL AMENDMENT FOR ONGOING PHASE 1 COTI-2 TRIAL IN MAY 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below